Unknown

Dataset Information

0

Design and evaluation of novel glutaminase inhibitors.


ABSTRACT: A novel set of GAC (kidney glutaminase isoform C) inhibitors able to inhibit the enzymatic activity of GAC and the growth of the triple negative MDA-MB-231 breast cancer cells with low nanomolar potency is described. Compounds in this series have a reduced number of rotatable bonds, improved ClogPs, microsomal stability and ligand efficiency when compared to the leading GAC inhibitors BPTES and CB-839. Property improvements were achieved by the replacement of the flexible n-diethylthio or the n-butyl moiety present in the leading inhibitors by heteroatom substituted heterocycloalkanes.

SUBMITTER: McDermott LA 

PROVIDER: S-EPMC6300166 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications


A novel set of GAC (kidney glutaminase isoform C) inhibitors able to inhibit the enzymatic activity of GAC and the growth of the triple negative MDA-MB-231 breast cancer cells with low nanomolar potency is described. Compounds in this series have a reduced number of rotatable bonds, improved ClogPs, microsomal stability and ligand efficiency when compared to the leading GAC inhibitors BPTES and CB-839. Property improvements were achieved by the replacement of the flexible n-diethylthio or the n-  ...[more]

Similar Datasets

| S-EPMC3539823 | biostudies-literature
| S-EPMC6274369 | biostudies-literature
| S-EPMC2833348 | biostudies-literature
| S-EPMC6804295 | biostudies-literature
| S-EPMC8276234 | biostudies-literature
| S-EPMC10263210 | biostudies-literature
| S-EPMC4027470 | biostudies-literature
| S-EPMC6274018 | biostudies-literature
| S-EPMC4094246 | biostudies-literature
| S-EPMC3254106 | biostudies-literature